Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5500
-0.0300 (-5.17%)
Apr 7, 2026, 3:32 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 200.38 million as of April 7, 2026. Its market cap has increased by 32.04% in one year.
Market Cap
200.38M
Enterprise Value
185.80M
Revenue
79.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.55
Market Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 200.38M, a decrease of -50.54%. That is a compound annual growth rate of -11.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 190.01M | -25.58% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 734.10M |
| PolyNovo | 645.94M |
| Lumos Diagnostics Holdings | 168.57M |
| EMVision Medical Devices | 145.91M |
| SomnoMed | 135.83M |
| Epiminder | 133.60M |
| Cleo Diagnostics | 75.96M |
| Compumedics | 57.93M |